Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 30

    1.

    Arsenite induces delayed mutagenesis and transformation in human osteosarcoma cells at extremely low concentrations.

    Mure K, Uddin AN, Lopez LC, Styblo M, Rossman TG.

    Environ Mol Mutagen. 2003;41(5):322-31.PMID: 12802802 [PubMed - indexed for MEDLINE]Related articles

    2.

    Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms.

    Hartwig A, Asmuss M, Ehleben I, Herzer U, Kostelac D, Pelzer A, Schwerdtle T, Bürkle A.

    Environ Health Perspect. 2002 Oct;110 Suppl 5:797-9. Review.PMID: 12426134 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Oxidative DNA adducts and DNA-protein cross-links are the major DNA lesions induced by arsenite.

    Bau DT, Wang TS, Chung CH, Wang AS, Wang AS, Jan KY.

    Environ Health Perspect. 2002 Oct;110 Suppl 5:753-6. Review.PMID: 12426126 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity.

    Maier A, Schumann BL, Chang X, Talaska G, Puga A.

    Mutat Res. 2002 May 27;517(1-2):101-11.PMID: 12034312 [PubMed - indexed for MEDLINE]Related articles

    5.

    Arsenic-induced NFkappaB transactivation through Erks- and JNKs-dependent pathways in mouse epidermal JB6 cells.

    Huang C, Li J, Ding M, Wang L, Shi X, Castranova V, Vallyathan V, Ju G, Costa M.

    Mol Cell Biochem. 2001 Jun;222(1-2):29-34.PMID: 11678607 [PubMed - indexed for MEDLINE]Related articles

    6.

    Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis.

    Rossman TG, Uddin AN, Burns FJ, Bosland MC.

    Toxicol Appl Pharmacol. 2001 Oct 1;176(1):64-71.PMID: 11578149 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts -- a possible mechanism for arsenite's comutagenicity.

    Vogt BL, Rossman TG.

    Mutat Res. 2001 Jul 1;478(1-2):159-68.PMID: 11406180 [PubMed - indexed for MEDLINE]Related articles

    8.

    Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes.

    Vega L, Styblo M, Patterson R, Cullen W, Wang C, Germolec D.

    Toxicol Appl Pharmacol. 2001 May 1;172(3):225-32.PMID: 11312651 [PubMed - indexed for MEDLINE]Related articles

    9.

    Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology.

    Chen H, Liu J, Merrick BA, Waalkes MP.

    Mol Carcinog. 2001 Feb;30(2):79-87.PMID: 11241755 [PubMed - indexed for MEDLINE]Related articles

    10.

    Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan.

    Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, Chen CJ.

    Am J Epidemiol. 2001 Mar 1;153(5):411-8.PMID: 11226969 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?

    Simeonova PP, Luster MI.

    J Environ Pathol Toxicol Oncol. 2000;19(3):281-6. Review.PMID: 10983894 [PubMed - indexed for MEDLINE]Related articles

    12.

    A novel polypeptide p10 expressed in tumor-promoter-treated murine epidermis and in untreated neonatal murine epidermis.

    Schlatterer K, Schlatterer B, Krauter G, Hecker E, Chandra P.

    Anticancer Res. 2000 Jan-Feb;20(1A):289-92.PMID: 10769669 [PubMed - indexed for MEDLINE]Related articles

    13.

    Sodium arsenate induces overproduction of interleukin-1alpha in murine keratinocytes: role of mitochondria.

    Corsini E, Asti L, Viviani B, Marinovich M, Galli CL.

    J Invest Dermatol. 1999 Nov;113(5):760-5.PMID: 10571731 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways.

    Barchowsky A, Roussel RR, Klei LR, James PE, Ganju N, Smith KR, Dudek EJ.

    Toxicol Appl Pharmacol. 1999 Aug 15;159(1):65-75.PMID: 10448126 [PubMed - indexed for MEDLINE]Related articles

    16.

    Arsenic: health effects, mechanisms of actions, and research issues.

    Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C, Waalkes M.

    Environ Health Perspect. 1999 Jul;107(7):593-7.PMID: 10379007 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors.

    Germolec DR, Spalding J, Yu HS, Chen GS, Simeonova PP, Humble MC, Bruccoleri A, Boorman GA, Foley JF, Yoshida T, Luster MI.

    Am J Pathol. 1998 Dec;153(6):1775-85.PMID: 9846968 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India.

    Guha Mazumder DN, Haque R, Ghosh N, De BK, Santra A, Chakraborty D, Smith AH.

    Int J Epidemiol. 1998 Oct;27(5):871-7.PMID: 9839746 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes.

    Hu Y, Su L, Snow ET.

    Mutat Res. 1998 Sep 11;408(3):203-18.PMID: 9806419 [PubMed - indexed for MEDLINE]Related articles

    20.

    Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species.

    Hei TK, Liu SX, Waldren C.

    Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8103-7.PMID: 9653147 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data